Pinpointing Pancreatic Cancer Susceptibility: The Power of Genetic Testing
Unlock the potential of genetic testing in assessing pancreatic cancer risk, guiding treatment, and informing families. Discover insights for better outcomes today.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Pancreatic Cancer, Susceptibility to, 3: The Promise of Genetic Testing
Genetic testing identifies pancreatic cancer risk, enabling early detection, personalized care, and informed treatment, empowering proactive health management.
Probing the Pathways: Genetic Testing for Parkinsonism-Dystonia, Infantile
Unlock insights into infantile parkinsonism-dystonia with genetic testing. Early diagnosis and personalized plans transform outcomes for affected children.
Polycystic Kidney Disease 2: Unlocking the Genetic Code to Combat a Silent Threat
Explore how genetic testing transforms PKD2 diagnosis and management, offering early detection, personalized treatments, and family planning guidance for a brighter future.
Polymicrogyria with Optic Nerve Hypoplasia: Understanding the Role of Genetic Testing in Diagnosis and Management
Explore how genetic testing aids in diagnosing polymicrogyria with optic nerve hypoplasia, informing personalized treatments and guiding family planning.
Primary Ciliary Dyskinesia 13: Precision in Prevention and Diagnosis
Explore how genetic testing transforms the diagnosis and management of Primary Ciliary Dyskinesia 13, improving early intervention and personalized treatment plans.
Pinpointing the Pathogen: Genetic Testing in Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant 5
Genetic testing, especially whole exome sequencing, unveils critical insights, aiding early diagnosis and management of Progressive External Ophthalmoplegia (PEO).
Purine-nucleoside Phosphorylase Deficiency: Understanding the Role of Genetic Testing
Explore Purine-nucleoside phosphorylase deficiency, its genetic causes, and how genetic testing aids in early diagnosis, personalized treatment, and management.